Advancing Digital Innovation to Reduce Financial Toxicity in Cancer Care and Research

Cancer is the 2nd leading cause of deaths in the U.S.

Among those that do survive, they are 2.5 times more likely to declare bankruptcy compared to those without a history of cancer.

Digital innovation holds promise to ensure access to quality care and reduce cost of cancer care. This set of open-access resources helps health systems and their partners address barriers to implementing digital health tools in cancer care and research.

Use the solutions catalog, core competencies, and financial navigation guide, to implement digital solutions to improve healthcare access, cost, and clinical outcomes for your patients. And use the Digital Navigation ROI Calculator and Digitally Enabled Patient Navigation Blueprint to quantify and maximize the ROI of your investments in digitally enabled patient navigation.

By using these resources, you can unlock the promise of digital innovation to minimize challenges in cancer care access and out-of-pocket cost measures associated with cancer, ensuring that financial worries do not overshadow the fight for recovery.

Use these Resources to Further Your Digital Innovation Strategy

Terms to Know

Access to Cancer Care

Flip to see content

Equity in access to cancer care in the Core Competencies guide refers to timely patient access to all-phase cancer care (e.g. screening, active treatment, and survivorship) as well as patient access to cancer clinical trials as a part of their care. (Adapted from: 1, 2, 3)

Financial Toxicity

Flip to see content

Financial toxicity refers to the cumulative impact of the economic, health, and psychosocial harm caused by the direct and indirect expenses that accrue to patients and their families as a result of a cancer diagnosis. Its potential results include material hardship, psychosocial distress, and treatment non-adherence. (Adapted from: 1, 2, 3, 4)

Partners

A multi-stakeholder team of leaders from a wide array of disciplines in cancer care, research, digital innovation, and regulatory science – alongside patient experts – dug into the root causes of access issues and financial toxicity in cancer. This work will help accelerate human-centered digital innovation to solve some of the most pressing challenges facing cancer patients, providers, and researchers.

Members also include the National Cancer Institute